berk-geneticgatewaystocovid-19-2020.pdf (96.53 kB)
Download fileGenetic gateways to COVID-19 infection: implications for risk, severity, and outcomes
journal contribution
posted on 2020-07-01, 00:00 authored by M Debnath, M Banerjee, Michael BerkMichael BerkThe dynamics, such as transmission, spatial epidemiology, and clinical course of Coronavirus Disease-2019 (COVID-19) have emerged as the most intriguing features and remain incompletely understood. The genetic landscape of an individual in particular, and a population in general seems to play a pivotal role in shaping the above COVID-19 dynamics. Considering the implications of host genes in the entry and replication of SARS-CoV-2 and in mounting the host immune response, it appears that multiple genes might be crucially involved in the above processes. Herein, we propose three potentially important genetic gateways to COVID-19 infection; these could explain at least in part the discrepancies of its spread, severity, and mortality. The variations within Angiotensin-converting enzyme 2 (ACE2) gene might constitute the first genetic gateway, influencing the spatial transmission dynamics of COVID-19. The Human Leukocyte Antigen locus, a master regulator of immunity against infection seems to be crucial in influencing susceptibility and severity of COVID-19 and can be the second genetic gateway. The genes regulating Toll-like receptor and complement pathways and subsequently cytokine storm induced exaggerated inflammatory pathways seem to underlie the severity of COVID-19, and such genes might represent the third genetic gateway. Host-pathogen interaction is a complex event and some additional genes might also contribute to the dynamics of COVID-19. Overall, these three genetic gateways proposed here might be the critical host determinants governing the risk, severity, and outcome of COVID-19. Genetic variations within these gateways could be key in influencing geographical discrepancies of COVID-19.
History
Journal
FASEB journalVolume
34Issue
7Pagination
8787 - 8795Publisher
WileyLocation
Chichester, Eng.Publisher DOI
Link to full text
ISSN
0892-6638eISSN
1530-6860Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Read the peer-reviewed publication
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineBiochemistry & Molecular BiologyBiologyCell BiologyLife Sciences & Biomedicine - Other TopicsACECOVID-19cytokine stormgeneticsHLAimmunitySARS-CoV-2ACUTE RESPIRATORY SYNDROMEANGIOTENSIN-CONVERTING ENZYME-2CLASS-IIHLA-ARECEPTORSARSALLELESRESISTANCEACE2ASSOCIATION